,Date,Title,Url
0,2017-01-04,부광약품스페인페레사보습용화장품브랜드리파바피엘라토상반기출시,http://www.fnnews.com/news/201701040922337773
1,2017-01-04,부광약품스페인브랜드로화장품사업본격화,http://www.ebn.co.kr/news/view/870326
2,2017-01-04,부광약품화장품출시로더모코스메틱분야공략,http://news.heraldcorp.com/view.php?ud=20170104000305
3,2017-01-04,부광약품화장품분야공략페레사리파바도입,http://www.bosa.co.kr/news/articleView.html?idxno=2052009
4,2017-01-04,부광약품더모코스메틱시장본격진출,http://medipana.com/news/news_viewer.asp?NewsNum=193627&MainKind=A&NewsKind=5&vCount=12&vKind=1
5,2017-01-04,부광약품화장품출시로더모코스메틱Dermocosmetic분야공략,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017010412420435033
6,2017-01-04,부광약품스페인화장품브랜드도입더모코스메틱공략나서다,http://www.mdtoday.co.kr/mdtoday/index.html?no=277394
7,2017-01-04,부광약품리파바피엘라토출시화장품시장본격진출,http://www.newsis.com/ar_detail/view.html?ar_id=NISX20170104_0014619837&cID=10434&pID=13000
8,2017-01-04,부광약품스페인페레화장품리파바피엘라토올상반기국내출시,http://www.viva100.com/main/view.php?key=20170104020018797
9,2017-01-05,부광약품어린이치약2개제품판매업무정지3개월행정처분,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=202551
10,2017-01-05,부광약품LID치료제개발단계희귀의약품지정,http://view.asiae.co.kr/news/view.htm?idxno=2017010514132002859
11,2017-01-05,부광약품JM010식약처개발단계희귀의약품지정,http://www.fnnews.com/news/201701051410341787
12,2017-01-05,부광약품LID치료제개발단계희귀의약품지정,http://stock.hankyung.com/news/app/newsview.php?aid=2017010507656
13,2017-01-05,부광약품이상운동파킨슨병치료제JM100희귀약지정받아,http://news.kmib.co.kr/article/view.asp?arcid=0011178991&code=61171911&cp=nv
14,2017-01-05,부광약품LID치료제개발단계희귀의약품승인,http://www.newspim.com/news/view/20170105000292
15,2017-01-05,부광약품LID치료제JM010개발단계희귀의약품지정승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202579
16,2017-01-05,부광약품LID치료제개발단계희귀의약품지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=277458
17,2017-01-05,부광약품화장품출시더모코스메틱분야공략,http://www.kukinews.com/news/article.html?no=422015
18,2017-01-05,부광약품LID치료제개발단계희귀의약품지정,http://biz.newdaily.co.kr/news/article.html?no=10122896
19,2017-01-05,식약처부광약품JM010희귀의약품지정,http://www.dailypharm.com/News/220760
20,2017-01-05,부광약품LID치료제개발단계희귀의약품지정,http://www.ebn.co.kr/news/view/870607
21,2017-01-05,부광약품파킨슨병운동장애치료물질개발단계약품지정,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170105133400017&did=1195m
22,2017-01-05,부광약품파킨슨병운동장애치료제개발단계희귀의약품지정,http://news1.kr/articles/?2877840
23,2017-01-05,부광약품파킨슨병운동장애치료물질개발단계약품지정”,http://www.sedaily.com/NewsView/1OAP8HV41P
24,2017-01-05,부광약품파킨슨병운동장애치료후보물질JM010개발단계희귀의약품지정,http://sports.khan.co.kr/news/sk_index.html?art_id=201701051629003&sec_id=560101&pt=nv
25,2017-01-05,부광약품LID치료제개발단계희귀약지정,http://www.monews.co.kr/news/articleView.html?idxno=96386
26,2017-01-05,부광약품파킨슨병운동장애치료제개발단계희귀의약품지정”,http://biz.chosun.com/site/data/html_dir/2017/01/05/2017010502106.html
27,2017-01-05,부광약품파킨슨병운동장애치료물질개발단계약품지정,http://www.dt.co.kr/contents.html?article_no=2017010502109976029005
28,2017-01-05,부광약품LID치료제JM010개발단계희귀약지정,http://medipana.com/news/news_viewer.asp?NewsNum=193705&MainKind=A&NewsKind=5&vCount=12&vKind=1
29,2017-01-05,부광약품파킨슨병LID치료제JM010개발단계희귀의약품지정,http://www.viva100.com/main/view.php?key=20170105020018809
30,2017-01-05,부광약품LID치료제개발단계희귀의약품지정승인,http://www.ekn.kr/news/article.html?no=260070
31,2017-01-06,부광약품치약관리소홀로줄줄이행정처분,http://www.docdocdoc.co.kr/?p=238758
32,2017-01-06,부광약품파킨슨병치료제JM010개발단계희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20170106000117
33,2017-01-06,부광약품치약원료검정소홀로행정처분받아,http://www.finomy.com/news/articleView.html?idxno=42252
34,2017-01-06,부광약품LID치료제JM010개발단계희귀의약품지정,http://www.kukinews.com/news/article.html?no=422322
35,2017-01-06,부광약품어린이용치약3개월판매정지행정처분,http://www.rapportian.com/news/articleView.html?idxno=101370
36,2017-01-08,안티프라그부광약품치약잇따라행정처분,http://www.mdtoday.co.kr/mdtoday/index.html?no=277548
37,2017-01-09,부광약품위암표적항암제아파티닙상용화기대,http://www.dailypharm.com/News/220864
38,2017-01-09,부광약품일부치약에식약처행정처분,http://www.sisafocus.co.kr/news/articleView.html?idxno=155728
39,2017-01-18,부광약품스톡옵션고배당정보유출의혹,http://www.breaknews.com/sub_read.html?uid=486598§ion=sc3
40,2017-01-24,부광약품㈜각부문신입및경력사원모집1월31일채용마감,http://www.ekn.kr/news/article.html?no=263763
41,2017-01-25,부광약품조직개편단행RD성과주의강화,http://www.newspim.com/news/view/20170125000194
42,2017-01-25,부광약품조직개편단행‥권한과책임강화,http://medipana.com/news/news_viewer.asp?NewsNum=194525&MainKind=A&NewsKind=5&vCount=12&vKind=1
43,2017-01-25,부광약품인사및조직제도개편QuantumUp시동,http://www.dailian.co.kr/news/view/608710/?sc=naver
44,2017-01-25,부광약품인사조직개편,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71047
45,2017-01-25,부광약품3본부1RD부분으로조직제도개편단행각부문책임강화,http://www.ekn.kr/news/article.html?no=263979
46,2017-01-25,부광약품조직개편단행,http://www.dt.co.kr/contents.html?article_no=2017012502109976029006
47,2017-01-25,부광약품각부문권한과책임강화하는조직개편단행,http://www.fnnews.com/news/201701251546463106
48,2017-01-25,부광약품인사및조직제도개편QuantumUp시동,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203109
49,2017-01-25,부광약품조직개편각부문책임강화,http://www.shinailbo.co.kr/news/articleView.html?idxno=554129
50,2017-01-25,부광약품조직제도개편부문별권한과책임강화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017012518061038831
51,2017-01-25,부광약품조직개편단행각부문별권한책임강화,http://biz.newdaily.co.kr/news/article.html?no=10124476
52,2017-01-25,부광약품조직개편각부문권한과책임강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=278298
53,2017-01-25,부광약품3개사업본부체제로조직개편연구개발에집중,http://www.rapportian.com/news/articleView.html?idxno=101668
54,2017-01-25,부광약품성과및RD중심조직개편권한책임강화,http://www.viva100.com/main/view.php?key=20170125020018965
55,2017-01-26,부광약품RD중심회사성장위해조직개편,http://www.monews.co.kr/news/articleView.html?idxno=97182
56,2017-01-26,부광약품RD집중위한조직개편,http://www.bosa.co.kr/news/articleView.html?idxno=2053674
57,2017-01-26,부광약품조직개편RD강화,http://www.ajunews.com/view/20170126081344780
58,2017-01-26,부광약품조직개편단행RD강화,http://view.asiae.co.kr/news/view.htm?idxno=2017012610345809695
59,2017-01-26,부광약품인사제도개선등개편단행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038254
60,2017-01-26,부광약품인사조직개편으로QuantumUp시동,http://www.kpanews.co.kr/article/show.asp?idx=180757&table=article&category=D
61,2017-01-26,부광약품작년매출1386억영업익85억전년비25↓633↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02968406615801656
62,2017-01-26,공시부광약품지난해영업익85억전년비633↓,http://www.newsway.co.kr/view.php?tp=1&ud=2017012614172836559
63,2017-01-26,부광약품지난해영업익633감소,http://www.sedaily.com/NewsView/1OAYVQ8ET4
64,2017-01-26,부광약품지난해영업이익85억원전년比63↓,http://biz.chosun.com/site/data/html_dir/2017/01/26/2017012601437.html
65,2017-01-26,부광약품지난해영업익85억전년比633↓,http://stock.hankyung.com/news/app/newsview.php?aid=2017012647156
66,2017-01-26,부광약품지난해영업익85억전년比633↓,http://www.mt.co.kr/view/mtview.php?type=1&no=2017012614350633470&outlink=1
67,2017-01-26,부광약품지난해영업익85억원전년比63↓,http://www.newspim.com/news/view/20170126000302
68,2017-01-26,부광약품지난해영업이익전년대비633↓,http://www.g-enews.com/ko-kr/news/article/news_all/201701261441421702237_1/article.html
69,2017-01-26,부광약품영업순이익감소RD투자비증가영향,http://medipana.com/news/news_viewer.asp?NewsNum=194592&MainKind=A&NewsKind=5&vCount=12&vKind=1
70,2017-01-26,부광약품지난해영업익85억3000만원전년대비633감소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1447799
71,2017-01-26,부광약품지난해연결영업익85억전년比63↓,http://www.newsis.com/view/?id=NISX20170126_0014667780&cID=10401&pID=10400
72,2017-02-01,더벨영업이익절벽부광약품RD딜레마,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201701310100055150003261
73,2017-02-12,부광약품당뇨병신약임상2b상승인기술수출추진,http://news1.kr/articles/?2909587
74,2017-02-13,부광약품당뇨신약MLR10232상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038910
75,2017-02-14,부광약품연구개발RD비중높이며혁신속도,http://www.dailymedi.com/detail.php?number=815746&thread=22r05
76,2017-02-14,부광약품美메리얼사와당뇨신약국내임상2b상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=279179
77,2017-02-14,2017한국여자바둑리그개막16일부광약품vs포스코켐텍맞대결,http://www.metroseoul.co.kr/news/newsview?newscd=2017021400101
78,2017-02-15,부광약품목표달성다짐‥RD비전공유,http://medipana.com/news/news_viewer.asp?NewsNum=195311&MainKind=A&NewsKind=5&vCount=12&vKind=1
79,2017-02-15,부광약품새인센티브제도시행임직원과이익공유,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203582
80,2017-02-15,유희원부광약품사장신약개발순조롭게진행인재등용에주력,http://www.rapportian.com/news/articleView.html?idxno=101972
81,2017-02-15,부광약품새인센티브제도입임직원과이익공유”,http://www.viva100.com/main/view.php?key=20170215020019113
82,2017-02-23,기업분석부광약품최근5년경영성적,http://www.ekn.kr/news/article.html?no=269732
83,2017-02-25,부광약품동급대결에서강했다,http://baduk.hangame.com/news.nhn?gseq=40529&m=view&page=&searchfield=&leagueseq=&searchtext=
84,2017-02-27,부광약품다음달17일정기주주총회개최,http://www.mt.co.kr/view/mtview.php?type=1&no=2017022711575315771&outlink=1
85,2017-02-27,부광약품내달17일정기주총개최,http://view.asiae.co.kr/news/view.htm?idxno=2017022713331727271
86,2017-03-02,배당금부광약품김동연회장최다‥5억이상19명,http://medipana.com/news/news_viewer.asp?NewsNum=195911&MainKind=A&NewsKind=5&vCount=12&vKind=1
87,2017-03-02,제약주하락세회복속제일약품부광약품은부진,http://www.mdtoday.co.kr/mdtoday/index.html?no=280373
88,2017-03-09,부광약품연결기준영업익순익감소RD비24증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204217
89,2017-03-13,더벨부광약품오너2세이끌던자회사청산,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201703090100018010001140
90,2017-03-15,fnRASSI부광약품52주신저가경신231↓,http://www.fnnews.com/news/201703150949045055
91,2017-03-15,fnRASSI부광약품52주신저가경신277↓,http://www.fnnews.com/news/201703151336274223
92,2017-03-17,부광약품제57기주주총회개최,http://www.dailypharm.com/News/223314
93,2017-03-20,부광약품실적주가최악최대주주는배당잔치,http://www.etoday.co.kr/news/section/newsview.php?idxno=1469690
94,2017-03-21,부광약품JM010등4품목개발단계희귀의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=204550
95,2017-03-28,부광약품캐나다바이오투자펀드410수익거둬,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703280197
96,2017-03-28,부광약품미제약사CoLucid투자로58억원수취,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204728
97,2017-03-28,부광약품미국제약사투자로58억수취400수익,http://www.g-enews.com/ko-kr/news/article/news_all/201703281032134099e6a49afa8d_1/article.html
98,2017-03-28,부광약품美제약사콜루시드투자58억수취,http://www.dailymedi.com/detail.php?number=817136&thread=22r05
99,2017-03-28,부광약품해외벤처투자로420수익실현,http://www.mt.co.kr/view/mtview.php?type=1&no=2017032810271308429&outlink=1
100,2017-03-28,부광약품미제약사CoLucid투자로58억원수취,http://www.kukinews.com/news/article.html?no=442801
101,2017-03-28,부광약품미제약사콜루시드투자로400수익,http://stock.hankyung.com/news/app/newsview.php?aid=2017032834466
102,2017-03-28,부광약품미국제약사콜루시드투자로58억수취,http://medipana.com/news/news_viewer.asp?NewsNum=197178&MainKind=A&NewsKind=5&vCount=12&vKind=1
103,2017-03-28,부광약품캐나다바이오투자펀드로52억원수익,http://www.ebn.co.kr/news/view/884029
104,2017-03-28,부광약품미제약사펀드투자58억원수익,http://www.dailypharm.com/News/223709
105,2017-03-28,부광약품해외바이오벤처투자로높은수익,http://www.rapportian.com/news/articleView.html?idxno=102857
106,2017-03-28,부광약품미제약사콜루시드투자로400수익,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017032812161556562
107,2017-03-28,부광약품美제약사에투자40수익,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71973
108,2017-03-28,부광약품미제약사CoLucid투자로58억원수취,http://www.mdtoday.co.kr/mdtoday/index.html?no=282226
109,2017-03-28,부광약품해외바이오벤처투자400수익,http://www.newspim.com/news/view/20170328000218
110,2017-03-28,부광약품美제약사콜루시드투자수익58억원,http://www.finomy.com/news/articleView.html?idxno=43792
111,2017-03-28,부광약품캐나다바이오투자로58억결실,http://www.ekn.kr/news/article.html?no=277059
112,2017-03-28,부광약품美제약사에투자해58억원수취,http://www.m-i.kr/news/articleView.html?idxno=299850
113,2017-03-28,부광약품미국제약사콜루시드투자로400수익거둬58억원수취”,http://biz.chosun.com/site/data/html_dir/2017/03/28/2017032802159.html
114,2017-03-28,부광약품미국제약사투자로58억원수익,http://www.dt.co.kr/contents.html?article_no=2017032802109976029002
115,2017-03-28,부광약품美바이오벤처콜루시드투자해58억원수취,http://www.viva100.com/main/view.php?key=20170328020019468
116,2017-03-29,부광약품美제약사투자로58억수익年영업익25규모,http://view.asiae.co.kr/news/view.htm?idxno=2017032908473761035
117,2017-03-29,부광약품편두통신약개발미국제약사투자로58억수익,http://news.kmib.co.kr/article/view.asp?arcid=0011361813&code=61141411&cp=nv
118,2017-03-29,부광약품주식회사4월2일일까지신입및경력사원모집,http://www.ekn.kr/news/article.html?no=277414
119,2017-04-02,한미약품부광약품국내제약업계RD투자비중금액1위,http://www.ekn.kr/news/article.html?no=278306
120,2017-04-07,부광약품조현병신약루라시돈국내라이선스계약,http://www.newspim.com/news/view/20170407000233
121,2017-04-07,부광약품CNS포트폴리오강화‥매출도약기대,http://medipana.com/news/news_viewer.asp?NewsNum=197711&MainKind=A&NewsKind=5&vCount=12&vKind=1
122,2017-04-07,부광약품조현병신약루라시돈도입,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170407098000017&did=1195m
123,2017-04-07,부광약품조현병치료제루라시돈판매계약,http://www.ebn.co.kr/news/view/885933
124,2017-04-07,부광약품스미토모다이닛폰사의조현병치료제루라시돈국내독점라이센스계약체결,http://www.fnnews.com/news/201704071458424752
125,2017-04-07,부광약품조현병치료제루라시돈국내판매독점계약,http://www.newsis.com/view/?id=NISX20170407_0014816537&cID=10434&pID=13000
126,2017-04-07,부광약품日조현병신약라투다국내도입,http://news1.kr/articles/?2960524
127,2017-04-07,부광약품일본다이닛폰스미토모제약과조현병신약루라시돈도입계약,http://biz.chosun.com/site/data/html_dir/2017/04/07/2017040701896.html
128,2017-04-07,부광약품조현병치료제루라시돈국내판매계약체결,http://www.rapportian.com/news/articleView.html?idxno=103115
129,2017-04-07,부광약품조현병치료제루라시돈국내판권확보,http://www.sedaily.com/NewsView/1OEJZ2S95T
130,2017-04-07,아파야챙길래광동제약부광약품신라젠外,http://www.g-enews.com/ko-kr/news/article/news_all/201704071552561892e6a49afa8d_1/article.html
131,2017-04-07,부광약품조현병신약루라시돈독점판매계약,http://www.bosa.co.kr/news/articleView.html?idxno=2058587
132,2017-04-07,부광약품조현병치료제루라시돈국내공급,http://www.dailymedi.com/detail.php?number=817530&thread=22r05
133,2017-04-07,부광약품조현병신약루라시돈국내판권계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=283183
134,2017-04-07,부광약품조현병신약루라시돈도입,http://www.dt.co.kr/contents.html?article_no=2017040702109976029003
135,2017-04-07,부광약품조현병신약日루라시라이센스독점계약,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72171
136,2017-04-07,부광약품조현병신약루라시돈도입,http://view.asiae.co.kr/news/view.htm?idxno=2017040717234523366
137,2017-04-07,부광약품조현병신약루라시돈독점판매계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205066
138,2017-04-07,조현병신약루라시돈부광약품판매맡아,http://www.monews.co.kr/news/articleView.html?idxno=99955
139,2017-04-07,부광약품스미토모다이닛폰사의조현병신약루라시돈도입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017040717260358495
140,2017-04-07,부광약품조현병신약루라시돈국내라이선스계약,http://www.ekn.kr/news/article.html?no=279777
141,2017-04-07,부광약품조현병신약루라시돈독점판매,http://www.fnnews.com/news/201704071818187552
142,2017-04-10,부광약품日조현병치료제개발라이선스계약체결,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041034
143,2017-04-12,fnRASSI부광약품52주신저가기록213↓,http://www.fnnews.com/news/201704121449229271
144,2017-04-21,코웨이부광약품과대배당vsSM엔터과소배당기업지목,http://www.newsis.com/view/?id=NISX20170420_0014843955&cID=10401&pID=10400
145,2017-04-21,종합코웨이부광약품과대배당vsSM엔터과소배당기업지목,http://www.newsis.com/view/?id=NISX20170421_0014846050&cID=10401&pID=10400
146,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://www.ebn.co.kr/news/view/888231
147,2017-04-21,부광약품바르는여드름치료제클리톡출시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170421075700017&did=1195m
148,2017-04-21,아파야챙길래동국제약부광약품,http://www.g-enews.com/ko-kr/news/article/news_all/201704211115211682e6a49afa8d_1/article.html
149,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://medipana.com/news/news_viewer.asp?NewsNum=198367&MainKind=A&NewsKind=5&vCount=12&vKind=1
150,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://www.rapportian.com/news/articleView.html?idxno=103388
151,2017-04-21,부광약품여드름치료클리톡외용액2출시,http://www.dailypharm.com/News/224632
152,2017-04-21,부광약품바르는여드름치료제클리톡출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041528
153,2017-04-21,부광약품여드름치료제클리톡외용액2출시손대지않고톡톡,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017042113400482928
154,2017-04-21,부광약품바르는여드름치료제클리톡외용액2출시,http://news1.kr/articles/?2973889
155,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://www.finomy.com/news/articleView.html?idxno=44329
156,2017-04-21,부광약품바르는여드름치료제클리톡2출시,http://www.ekn.kr/news/article.html?no=282814
157,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://www.kpanews.co.kr/article/show.asp?idx=183181&table=article&category=D
158,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://www.m-i.kr/news/articleView.html?idxno=306053
159,2017-04-21,부광약품여드름치료제클리톡외용액2출시,http://www.viva100.com/main/view.php?key=20170421020019718
160,2017-04-23,부광약품여드름치료제클리톡출시,http://www.newstomato.com/ReadNews.aspx?no=748372
161,2017-04-24,과대배당기업에코웨이부광약품성장갉아먹을수있어,http://www.asiatoday.co.kr/view.php?key=20170424010014563
162,2017-04-24,부광약품여드름치료제클리톡외용액2,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72402
163,2017-04-24,제약소식부광약품여드름치료제클리톡외용액2출시外,http://www.kukinews.com/news/article.html?no=449666
164,2017-04-30,최정의부광약품막차로4강PS팀확정,http://baduk.hangame.com/news.nhn?gseq=41248&m=view&page=&searchfield=&leagueseq=&searchtext=
165,2017-04-30,부광약품막차로4강합류포스트시즌진출4개팀확정,http://www.metroseoul.co.kr/news/newsview?newscd=2017043000008
166,2017-05-01,서울부광약품막차로2017여자바둑리그포스트시즌진출,http://sports.chosun.com/news/ntype.htm?id=201705010100006590000237&servicedate=20170501
167,2017-05-01,녹십자대웅제약부광약품삼성제약간기능개선일부제품식약처재평가결과효능효과불인정,http://sports.khan.co.kr/news/sk_index.html?art_id=201705011555003&sec_id=561801&pt=nv
168,2017-05-08,fnRASSI부광약품402오르며거래량증가,http://www.fnnews.com/news/201705080928278074
169,2017-05-10,마켓인사이트부광약품의폭탄배당경영분쟁불씨지피나,http://stock.hankyung.com/news/app/newsview.php?aid=201705084683u
170,2017-05-15,부광약품1분기매출339억영업이익전년비소폭증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205904
171,2017-05-16,최정앞세운부광약품플레이오프진출,http://baduk.hangame.com/news.nhn?gseq=41543&m=view&page=&searchfield=&leagueseq=&searchtext=
172,2017-05-16,부광약품호반건설꺾고여자바둑리그플레이오프진출,http://www.sportsseoul.com/news/read/512449
173,2017-05-16,2017엠디엠한국여자바둑리그부광약품호반건설20꺾고플레이오프진출,http://sports.hankooki.com/lpage/moresports/201705/sp20170516100309136560.htm
174,2017-05-18,부광약품메디톡스의메디톡신공동판매유통,http://medipana.com/news/news_viewer.asp?NewsNum=200397&MainKind=A&NewsKind=5&vCount=12&vKind=1
175,2017-05-18,부광약품메디톡신주200단위공동판권취득,http://www.rapportian.com/news/articleView.html?idxno=103797
176,2017-05-18,디펜딩챔피언서울부광약품플레이오프진출,http://www.queen.co.kr/news/articleView.html?idxno=205013
177,2017-05-18,부광약품에자이로부터치료용메디톡신주공동판권취득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206090
178,2017-05-18,부광약품메디톡신주200단위공동판권취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=286023
179,2017-05-18,부광약품에자이와보툴리눔톡신메디톡신200단위공동판매,http://www.viva100.com/main/view.php?key=20170518020019922
180,2017-05-19,부광약품한국에자이와메디톡신공동판매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1042311
181,2017-05-19,더벨부광약품계열부광메디카주요임원진교체,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201705180100023630001434
182,2017-06-14,부광약품㈜임상부문신입및경력사원모집6월18일마감,http://www.ekn.kr/news/article.html?no=293523
183,2017-06-28,부광약품훼로바부동의1위빈혈약철결핍용임신부용2종첫선,http://view.asiae.co.kr/news/view.htm?idxno=2017062808033179708
184,2017-07-04,부광약품투자美에이서테라퓨틱스나스닥상장,http://www.kpanews.co.kr/article/show.asp?idx=185257&table=article&category=D
185,2017-07-04,부광약품투자美제약사나스닥상장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73419
186,2017-07-04,부광약품투자美에이서테라퓨틱스오펙사와합병통해나스닥상장,http://biz.chosun.com/site/data/html_dir/2017/07/04/2017070401472.html
187,2017-07-04,부광약품美투자사나스닥상장,http://www.medigatenews.com/news/591956677
188,2017-07-04,부광약품투자미국희귀의약품회사나스닥상장,http://medipana.com/news/news_viewer.asp?NewsNum=203586&MainKind=A&NewsKind=5&vCount=12&vKind=1
189,2017-07-04,부광약품투자사美에이서나스닥상장,http://news.hankyung.com/article/2017070432166
190,2017-07-04,부광약품투자사美에이서나스닥상장,http://www.newspim.com/news/view/20170704000182
191,2017-07-04,부광약품투자美에이서테라퓨틱스나스닥상장,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=207464
192,2017-07-04,부광약품투자美AcerTherapeutics나스닥상장,http://www.bosa.co.kr/news/articleView.html?idxno=2064175
193,2017-07-04,부광약품이투자한미국제약기업합병으로나스닥상장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044007
194,2017-07-04,부광약품투자한미국제약사에이서테파퓨틱스나스닥상장,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017070412472866535
195,2017-07-04,부광약품투자사美에이서나스닥상장,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707040206
196,2017-07-04,부광약품투자美회사나스닥상장,http://www.edaily.co.kr/news/newspath.asp?newsid=03450566615991240
197,2017-07-04,부광약품투자사美에이서나스닥상장,http://www.asiae.co.kr/news/view.htm?idxno=2017070415215988223
198,2017-07-04,부광약품투자사미에이서테라퓨틱스나스닥상장사와합병,http://www.fnnews.com/news/201707041522077909
199,2017-07-04,부광약품46억투자한美바이오기업나스닥에상장,http://www.rapportian.com/news/articleView.html?idxno=104642
200,2017-07-04,부광약품투자사美에이서나스닥상장,http://www.newsis.com/view/?id=NISX20170704_0000031557&cID=13001&pID=13000
201,2017-07-04,부광약품13지분투자한미국제약사나스닥상장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170704161000017&did=1195m
202,2017-07-04,부광약품지분투자美제약사에이서테라퓨틱스나스닥상장,http://www.ebn.co.kr/news/view/899399
203,2017-07-04,부광약품″13지분투자한美제약사나스닥상장″,http://www.fnnews.com/news/201707041645396464
204,2017-07-04,부광약품투자중인美제약사에이서나스닥상장,http://www.mdtoday.co.kr/mdtoday/index.html?no=289871
205,2017-07-04,부광약품투자미국희귀의약품개발사나스닥상장,http://www.sportsseoul.com/news/read/528500
206,2017-07-04,부광약품투자美에이서나스닥상장사오펙사와합병,http://www.viva100.com/main/view.php?key=20170704020020318
207,2017-07-05,부광약품지분투자美제약사나스닥상장,https://cnbc.sbs.co.kr/article_hub/10000865313?division=NAVER
208,2017-07-05,부광약품13지분투자한미국에이서나스닥상장,http://www.dt.co.kr/contents.html?article_no=2017070402109976029009&ref=naver
209,2017-07-05,부광약품투자美AcerTherapeutics나스닥상장,http://www.monews.co.kr/news/articleView.html?idxno=103255
210,2017-07-20,비바100부광약품파킨슨병당뇨병신약으로부활노린다,http://www.viva100.com/main/view.php?key=20170719010006790
211,2017-08-04,부광약품조현병신약라투다임상3상허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=292333
212,2017-08-11,치옥타시드에덱시드로시장평정부광약품,http://www.dailymedi.com/detail.php?number=821422&thread=22r05
213,2017-08-14,부광약품덱시드성장그래프그리며보폭한걸음전진,http://www.mdtoday.co.kr/mdtoday/index.html?no=293005
214,2017-08-15,신약개발무게둔부광약품상반기RD투자에만22투입,http://www.mdtoday.co.kr/mdtoday/index.html?no=293134
215,2017-08-16,부광약품상반기매출728억영업익전년비61감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208731
216,2017-08-16,부광약품RD비중1위매출액대비22,http://www.m-i.kr/news/articleView.html?idxno=334942
217,2017-08-30,부광약품당뇨병신약첨단의료기술개발신약개발지원과제선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209254
218,2017-08-30,부광약품당뇨병신약정부지원금20억원획득,http://medipana.com/news/news_viewer.asp?NewsNum=206075&MainKind=A&NewsKind=5&vCount=12&vKind=1
219,2017-08-30,부광약품개발당뇨병신약신약개발지원과제선정,http://www.medicaltimes.com/News/1113514
220,2017-08-30,생생코스피부광약품당뇨병신약보건부첨단의료기술개발과제로선정,http://news.heraldcorp.com/view.php?ud=20170830000660
221,2017-08-30,부광약품당뇨신약정부과제선정,http://www.medigatenews.com/news/1889396100
222,2017-08-30,부광약품신약개발지원과제선정,http://www.newstomato.com/ReadNews.aspx?no=774668
223,2017-08-30,부광약품당뇨병치료신약후보물질정부지원과제로선정,http://www.rapportian.com/news/articleView.html?idxno=105842
224,2017-08-30,부광약품MLR1023정부신약개발지원과제선정,http://www.dailymedi.com/detail.php?number=821979&thread=22r05
225,2017-08-30,부광약품당뇨병신약첨단의료기술개발신약개발지원과제선정,http://www.newspim.com/news/view/20170830000158
226,2017-08-30,부광약품당뇨병신약정부신약개발지원과제선정,http://www.dt.co.kr/contents.html?article_no=2017083002109976029004&ref=naver
227,2017-08-30,부광약품당뇨병신약개발지원과제선정,http://www.kpanews.co.kr/article/show.asp?idx=186673&table=article&category=D
228,2017-08-30,부광약품당뇨병신약개발속도박차,http://www.m-i.kr/news/articleView.html?idxno=338794
229,2017-08-30,부광약품당뇨병신약MLR1023정부지원과제선정,http://news.hankyung.com/article/201708306550f
230,2017-08-30,부광약품당뇨병신약MLR1023첨단의료기술개발신약개발지원과제선정,http://sports.hankooki.com/lpage/life/201708/sp20170830181903136800.htm
231,2017-08-30,부광약품당뇨병신약MLR1023복지부지원과제선정,https://cnbc.sbs.co.kr/article_hub/10000872673?division=NAVER
232,2017-08-30,부광약품당뇨병신약MLR1023복지부지원과제선정,http://www.viva100.com/main/view.php?key=20170830020020752
233,2017-08-31,부광약품당뇨신약복지부신약개발지원과제선정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046077
234,2017-08-31,부광약품당뇨병신약MLR1023개발지원과제선정,http://www.kpanews.co.kr/article/show.asp?idx=186695&table=article&category=D
235,2017-08-31,부광약품당뇨신약정부지원과제선정,http://www.monews.co.kr/news/articleView.html?idxno=105095
236,2017-09-01,부광약품당뇨신약MLR1032정부지원금20억확보,http://www.mdtoday.co.kr/mdtoday/index.html?no=294611
237,2017-09-04,빅데이터MSI시장심리톱5KB금융신한지주한국항공우주후성부광약품,http://www.newsis.com/view/?id=NISX20170904_0000085201&cID=10401&pID=10400
238,2017-09-11,부광약품당뇨신약후기2상임상시험탄력,http://medipana.com/news/news_viewer.asp?NewsNum=206605&MainKind=A&NewsKind=5&vCount=12&vKind=1
239,2017-09-11,부광약품당뇨치료신약임상시험시작,http://www.kpinews.co.kr/news/articleView.html?idxno=53586
240,2017-09-11,부광약품당뇨신약후기임상2상환자등록개시,http://www.monews.co.kr/news/articleView.html?idxno=105465
241,2017-09-11,부광약품제2형당뇨병치료신약후기2상임상시험환자등록개시,http://www.sportsseoul.com/news/read/550265
242,2017-09-11,부광약품제2형당뇨병치료신약후기2상환자등록개시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209659
243,2017-09-11,부광약품제2형당뇨병치료신약후기2상임상시험환자등록개시,http://www.newsis.com/view/?id=NISX20170911_0000091930&cID=13001&pID=13000
244,2017-09-11,부광약품MLR1023후기2상임상환자등록개시,http://www.bosa.co.kr/news/articleView.html?idxno=2068376
245,2017-09-11,부광약품당뇨병치료신약후기2상임상개시,http://www.medicaltimes.com/News/1113781
246,2017-09-11,부광약품당뇨병신약후기2상임상환자등록개시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170911096400017&did=1195m
247,2017-09-11,부광약품당뇨병치료신약후기2상임상시험환자등록개시,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201709110215
248,2017-09-11,부광약품제2형당뇨병치료신약MLR1023”의후기2상임상시험환자등록개시,http://sports.hankooki.com/lpage/life/201709/sp20170911141645136800.htm
249,2017-09-11,부광약품제2형당뇨병치료제제2상환자등록시작,http://www.fnnews.com/news/201709111440463321
250,2017-09-11,부광약품당뇨병신약후기2상임상환자등록시작,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017091114391113550
251,2017-09-11,부광약품㈜PVPharmacovigilance부문신입및경력사원모집9월13일마감,http://www.ekn.kr/news/article.html?no=311641
252,2017-09-11,부광약품당뇨병신약후기2상환자등록,http://www.newspim.com/news/view/20170911000144
253,2017-09-11,부광약품당뇨병신약후기2상환자등록돌입,http://www.dt.co.kr/contents.html?article_no=2017091102109976029004&ref=naver
254,2017-09-11,부광약품2형당뇨병신약후기2상임상환자등록,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74425
255,2017-09-11,부광약품제2형당뇨신약MLR1023후기2상임상시험환자등록개시,http://www.mdtoday.co.kr/mdtoday/index.html?no=295354
256,2017-09-11,부광약품당뇽병신약후기2상임상환자등록개시,http://www.kpanews.co.kr/article/show.asp?idx=187019&table=article&category=D
257,2017-09-11,부광약품당뇨병치료신약후보물질2상환자등록시작,http://www.rapportian.com/news/articleView.html?idxno=106116
258,2017-09-11,부광약품당뇨치료제신약후기임상2상돌입,http://www.finomy.com/news/articleView.html?idxno=47532
259,2017-09-11,부광약품제2형당뇨병치료신약후기2상환자등록실시,http://www.m-i.kr/news/articleView.html?idxno=341992
260,2017-09-11,부광약품韓美서당뇨병치료제임상시험환자등록시작,http://www.edaily.co.kr/news/newspath.asp?newsid=03601446616059136
261,2017-09-11,부광약품제2형당뇨병치료신약후기임상2상환자등록개시,http://biz.chosun.com/site/data/html_dir/2017/09/11/2017091102149.html
262,2017-09-11,부광약품당뇨병신약MLR1023韓美2b상임상환자등록시작,http://www.viva100.com/main/view.php?key=20170911020020869
263,2017-09-12,부광약품제2형당뇨병치료제제2상임상시험환자등록시작,http://www.enewstoday.co.kr/news/articleView.html?idxno=1107776
264,2017-09-12,RD히든챔피언부광약품두마리토끼잡기성공할까,http://news.heraldcorp.com/view.php?ud=20170912000166
265,2017-09-12,부광약품제2형당뇨치료신약제2상임상시험본격화,http://news.kmib.co.kr/article/view.asp?arcid=0011749108&code=61171911&cp=nv
266,2017-09-12,부광약품두토끼잡기성공할까,http://news.heraldcorp.com/view.php?ud=20170912000404
267,2017-09-12,부광약품당뇨신약MLR1023후기2상환자등록시작,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046483
268,2017-09-12,부광약품당뇨병신약개발잰걸음후기2상임상환자등록시작,http://www.nextdaily.co.kr/news/article.html?id=20170912800040
269,2017-09-15,25편부광약품아락실1998년CF,http://www.dailypharm.com/News/230926
270,2017-09-29,26편부광약품훼로바1996년CF,http://www.dailypharm.com/News/231536
271,2017-10-11,단독부광약품멜리어사와공동개발당뇨병신약임상2상후기투여시작,http://www.nspna.com/news/?mode=view&newsid=244283
272,2017-10-19,부광약품㈜글로벌임상부문신입및경력사원모집10월31일마감,http://www.ekn.kr/news/article.html?no=318601
273,2017-10-20,단독부광약품투자한美바이오회사나스닥상장성공2배이상차익,http://www.nspna.com/news/?mode=view&newsid=245926
274,2017-10-23,부광약품10월31일화까지글로벌임상부문신입사원모집,http://www.ekn.kr/news/article.html?no=319306
275,2017-10-26,관심주부광약품당뇨병치료제중추신경치료제신약개발에RD집중투자,https://cnbc.sbs.co.kr/article_hub/10000879390?division=NAVER
276,2017-11-04,이재원전부광약품사장별세,http://medipana.com/news/news_viewer.asp?NewsNum=209144&MainKind=A&NewsKind=5&vCount=12&vKind=1
277,2017-11-13,실적발표부광약품원림한국석유공업심텍홀딩스,http://www.businesspost.co.kr/BP?command=article_view&num=64008
278,2017-11-14,ET투자뉴스부광약품17년3분기실적발표,http://www.etnews.com/20171114000052
279,2017-11-24,ET투자뉴스안트로젠지분변동부광약품주외8명183p감소2695보유,http://www.etnews.com/20171124000310
280,2017-11-27,더벨부광약품LID신약JM010FDA2b상가시화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201711240100044360002733
281,2017-12-04,부광약품보통주1주당200원현금배당,http://www.mt.co.kr/view/mtview.php?type=1&no=2017120413380032648&outlink=1
282,2017-12-04,부광약품보통주1주당200원현금배당,http://www.etoday.co.kr/news/section/newsview.php?idxno=1570311
283,2017-12-04,부광약품주당200원현금배당,http://news.hankyung.com/article/2017120472676
284,2017-12-04,부광약품보통주1주당01주주식배당,http://www.mt.co.kr/view/mtview.php?type=1&no=2017120413481058170&outlink=1
285,2017-12-04,부광약품주당200원01주배당결정,http://www.asiae.co.kr/news/view.htm?idxno=2017120413475795296
286,2017-12-04,부광약품오후2시11분까지매매거래정지,http://www.asiae.co.kr/news/view.htm?idxno=2017120413500004885
287,2017-12-04,한국거래소부광약품주식30분간매매정지,http://www.mt.co.kr/view/mtview.php?type=1&no=2017120413501036646&outlink=1
288,2017-12-04,부광약품주당01주주식배당결정,http://news.hankyung.com/article/2017120473176
289,2017-12-04,부광약품신주배당거래정지,http://www.edaily.co.kr/news/newspath.asp?newsid=02669926616155240
290,2017-12-04,부광약품보통주1주당200원현금배당,http://www.mediapen.com/news/view/317873
291,2017-12-04,부광약품오후2시11분까지매매거래정지,http://www.etoday.co.kr/news/section/newsview.php?idxno=1570320
292,2017-12-04,부광약품주당200원현금결산배당,http://www.newsis.com/view/?id=NISX20171204_0000166434&cID=10401&pID=10400
293,2017-12-04,부광약품보통주1주당200원현금배당01주주식배당,http://biz.chosun.com/site/data/html_dir/2017/12/04/2017120401725.html
294,2017-12-04,한국거래소부광약품주식거래30분간정지,http://www.newsis.com/view/?id=NISX20171204_0000166457&cID=10401&pID=10400
295,2017-12-04,부광약품보통주1주당200원현금배당,http://www.newsprime.co.kr/news/article.html?no=397640
296,2017-12-04,종합부광약품주당01주현금200원배당,http://www.newsis.com/view/?id=NISX20171204_0000166469&cID=10401&pID=10400
297,2017-12-04,부광약품주당01주주식배당결정,http://www.newspim.com/news/view/20171204000138
298,2017-12-04,부광약품보통주1주당200원현금배당01주주식배당”,http://www.mdtoday.co.kr/mdtoday/index.html?no=303784
299,2017-12-04,공시부광약품주당200원현금배당결정,http://www.viva100.com/main/view.php?key=20171204010000961
300,2017-12-04,거래소부광약품거래정지해제,http://www.viva100.com/main/view.php?key=20171204010000962
301,2017-12-04,부광약품주당200원현금배당결정,http://news.heraldcorp.com/view.php?ud=20171204000782
302,2017-12-04,한국거래소부광약품매매거래정지해제,http://www.ebn.co.kr/news/view/920251
303,2017-12-04,거래소부광약품매매거래정지해제,http://www.sedaily.com/NewsView/1OOQ3XVC3R
304,2017-12-04,부광약품보통주1주당200원현금배당결정,http://www.sedaily.com/NewsView/1OOQ3UTK21
305,2017-12-04,한국거래소부광약품매매거래정지해제,http://www.mdtoday.co.kr/mdtoday/index.html?no=303799
306,2017-12-04,부광약품주당200원현금배당,http://www.betanews.net:8080/article/775979.html
307,2017-12-04,배당금계절돌아와부광약품주당200원배당금결정,http://www.sisafocus.co.kr/news/articleView.html?idxno=170487
308,2017-12-04,부광약품1주당200원현금배당결정,http://www.cstimes.com/?mod=news&act=articleView&idxno=262080
309,2017-12-05,부광약품덱시드제네릭등장에환영,http://www.mdtoday.co.kr/mdtoday/index.html?no=303862
310,2017-12-27,10개상장제약사올해도주식배당‥부광약품18년째,http://medipana.com/news/news_viewer.asp?NewsNum=213711&MainKind=A&NewsKind=5&vCount=12&vKind=1
